Your session is about to expire
← Back to Search
Wound Care Product
Next Science Wound Gel Efficacy in Chronic Wound Versus Standard of Care
N/A
Waitlist Available
Research Sponsored by Next Science TM
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
All Individual Drugs Already Approved
Approved for 10 Other Conditions
No Placebo-Only Group
Summary
This is a 3 to 4 months, multi-site, prospective randomized clinical study of patients diagnosed with a chronic wound. The primary objective is to assess changes in healing rate, by measuring differences in wound area when treating chronic wounds with the Next Science Wound Gel compared to the Triple Antibiotic Ointment Neosporin (Standard of Care, SOC). At the end of the study period, patients may continue receiving their assigned study treatment provided they have signed the "Continuation of Treatment Informed Consent" and the rational for continuation is documented by the investigator.
Eligible Conditions
- Chronic Wounds
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Approved for 10 Other Conditions
This treatment demonstrated efficacy for 10 other conditions.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Next Science Wound GelExperimental Treatment1 Intervention
Daily direct application to the wound, covered with a conventional non-alginate dressing. Dressing should be changed daily or as directed by the health care provider.
Group II: Triple Antibiotic Ointment NeosporinActive Control1 Intervention
Daily direct application to the wound, covered with conventional dressing. Dressing should be changed daily or as directed by the health care provider.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Next Science Wound Gel
2014
N/A
~50
Find a Location
Who is running the clinical trial?
Next Science TMLead Sponsor
15 Previous Clinical Trials
9,481 Total Patients Enrolled
Mayo ClinicOTHER
3,355 Previous Clinical Trials
3,061,670 Total Patients Enrolled
Jacksonville Center For Clinical ResearchOTHER
2 Previous Clinical Trials
68 Total Patients Enrolled